文献速递糖尿病肥胖与代谢综合征

循环胆汁酸作为疾病诊断与预防的生物标志物

Circulating Bile Acids as Biomarkers for Disease Diagnosis and Prevention.
PubMed 文献 · J Clin Endocrinol Metab · 2023-01-01

本文综述了循环胆汁酸谱在肥胖、2型糖尿病、非酒精性脂肪性肝病、肝细胞癌、胆管癌、结肠癌和阿尔茨海默病等疾病中的变化,基于PubMed检索文献,指出异常胆汁酸谱是这些疾病发生发展的早期事件,可为诊断和预防生物标志物的开发提供基础。

要点

  • 肥胖、2型糖尿病、肝细胞癌、胆管癌或阿尔茨海默病患者循环胆汁酸谱存在特定改变。
  • 这些改变可能在这些疾病初次诊断之前很久就已存在。
  • 异常循环胆汁酸谱是肥胖、2型糖尿病、肝细胞癌和阿尔茨海默病发生发展的早期事件。

核心结论

  • 异常循环胆汁酸谱是肥胖、2型糖尿病、肝细胞癌和阿尔茨海默病发生发展的早期事件。
  • 胆汁酸的多效性作用解释了这些广泛的联系。
  • 循环胆汁酸谱可为开发用于广泛疾病诊断和预防的生物标志物提供基础。

研究设计与样本

  • 本综述基于从PubMed检索收集的原著和综述文献,检索关键词包括胆汁酸、肥胖、2型糖尿病、胰岛素抵抗、非酒精性脂肪性肝病、肝细胞癌、胆管癌、结肠癌和阿尔茨海默病等。

主要发现

  • 肥胖、2型糖尿病、肝细胞癌、胆管癌或阿尔茨海默病个体显示循环胆汁酸谱的特定改变,这些改变可能在这些疾病初次诊断之前很久就已存在。
  • 肥胖、胰岛素抵抗和非酒精性脂肪性肝病之间的复杂关系使建立胆汁酸谱与非酒精性脂肪性肝炎之间清晰独立的关联变得复杂。
  • 在非酒精性脂肪性肝病的整个谱系中可见总胆汁酸和几种胆汁酸物种水平的改变,随着组织学特征的恶化显示显著增加。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Bile acids (BAs) are pivotal signaling molecules that regulate energy metabolism and inflammation. Recent epidemiological studies have reported specific alterations in circulating BA profiles in certain disease states, including obesity, type 2 diabetes mellitus (T2DM), nonalcoholic fatty liver disease (NAFLD), and Alzheimer disease (AD). In the past decade, breakthroughs have been made regarding the translation of BA profiling into clinical use for disease prediction. In this review, we summarize and synthesize recent data on variation in circulating BA profiles in patients with various diseases to evaluate the value of these biomarkers in human plasma for early diagnosis. EVIDENCE ACQUISITION: This review is based on a collection of primary and review literature gathered from a PubMed search for BAs, obesity, T2DM, insulin resistance (IR), NAFLD, hepatocellular carcinoma (HCC), cholangiocarcinoma (CCA), colon cancer, and AD, among other keywords. EVIDENCE SYNTHESIS: Individuals with obesity, T2DM, HCC, CCA, or AD showed specific alterations in circulating BA profiles. These alterations may have existed long before the initial diagnosis of these diseases. The intricate relationship between obesity, IR, and NAFLD complicates the establishment of clear and independent associations between BA profiles and nonalcoholic steatohepatitis. Alterations in the levels of total BAs and several BA species were seen across the entire spectrum of NAFLD, demonstrating significant increases with the worsening of histological features. CONCLUSIONS: Aberrant circulating BA profiles are an early event in the onset and progression of obesity, T2DM, HCC, and AD. The pleiotropic effects of BAs explain these broad connections. Circulating BA profiles could provide a basis for the development of biomarkers for the diagnosis and prevention of a wide range of diseases.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Qi L, Chen Y. Circulating Bile Acids as Biomarkers for Disease Diagnosis and Prevention. J Clin Endocrinol Metab. 2023. PMID: 36374935. doi:10.1210/clinem/dgac659

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。